APO RESEARCH · REPORT
Bioresorbable Medical Material
The bioresorbable medical material in this report contains polylactic acid (PLA), polyglycolic acid (PGA), polysaccharides, polycaprolactone (PCL) and PLGA.
Product & engineering
Understand the product.
The bioresorbable medical material in this report contains polylactic acid (PLA), polyglycolic acid (PGA), polysaccharides, polycaprolactone (PCL) and PLGA.
Selected research
Industry Research
Bioresorbable Medical Material Industry Research Report 2026
Market perspective
The bioresorbable medical material in this report contains polylactic acid (PLA), polyglycolic acid (PGA), polysaccharides, polycaprolactone (PCL) and PLGA.
Global Bioresorbable Medical Material key players include Evonik, Corbion, DSM, Mitsui Chemicals, PCAS, etc. Global top five manufacturers hold a share over 50%.
USA is the largest market, with a share over 40%, followed by Europe and China, both have a share over 35% percent. In terms of product, PLA is the largest segment, with a share over 20%. And in terms of application, the largest application is Orthopedics, followed by Drug Delivery.
Read the full market overview
Report Scope
This report quantifies the global Bioresorbable Medical Material market in terms of revenue (US$ million) and, where applicable, sales volume (K MT), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K MT) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Bioresorbable Medical Material Market by Company
Evonik
Corbion
DSM
Mitsui Chemicals
PCAS
Poly-Med
KLS Martin
Bioresorbable Medical Material Segment by Type
Polylactic Acid (PLA)
Polyglycolic Acid (PGA)
Polysaccharides
Polycaprolactone (PCL)
PLGA
Bioresorbable Medical Material Segment by Application
Drug Delivery
Orthopedics
Others
Bioresorbable Medical Material Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bioresorbable Medical Material market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Bioresorbable Medical Material and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bioresorbable Medical Material.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Bioresorbable Medical Material manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Bioresorbable Medical Material by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Bioresorbable Medical Material in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Polylactic Acid (PLA)
- Polyglycolic Acid (PGA)
- Polysaccharides
- Polycaprolactone (PCL)
- PLGA
Applications
- Drug Delivery
- Orthopedics
- Others
Companies covered
- Evonik
- Corbion
- DSM
- Mitsui Chemicals
- PCAS
- Poly-Med
- KLS Martin
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Bioresorbable Medical Material Market Size (2021-2032)
- 2.2.2 Global Bioresorbable Medical Material Sales (2021-2032)
- 2.2.3 Global Bioresorbable Medical Material Market Average Price (2021-2032)
- 2.3 Bioresorbable Medical Material by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Polylactic Acid (PLA)
- 2.3.3 Polyglycolic Acid (PGA)
- 2.3.4 Polysaccharides
- 2.3.5 Polycaprolactone (PCL)
- 2.3.6 PLGA
- 2.4 Bioresorbable Medical Material by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Drug Delivery
- 2.4.3 Orthopedics
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Bioresorbable Medical Material Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Bioresorbable Medical Material Sales (K MT) of Manufacturers (2021-2026)
- 3.3 Global Bioresorbable Medical Material Revenue of Manufacturers (2021-2026)
- 3.4 Global Bioresorbable Medical Material Average Price by Manufacturers (2021-2026)
- 3.5 Global Bioresorbable Medical Material Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Bioresorbable Medical Material, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Bioresorbable Medical Material, Product Type & Application
- 3.8 Global Manufacturers of Bioresorbable Medical Material, Established Date
- 3.9 Global Bioresorbable Medical Material Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Evonik
- 4.1.1 Evonik Company Information
- 4.1.2 Evonik Business Overview
- 4.1.3 Evonik Bioresorbable Medical Material Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Evonik Bioresorbable Medical Material Product Portfolio
- 4.1.5 Evonik Recent Developments
- 4.2 Corbion
- 4.2.1 Corbion Company Information
- 4.2.2 Corbion Business Overview
- 4.2.3 Corbion Bioresorbable Medical Material Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Corbion Bioresorbable Medical Material Product Portfolio
- 4.2.5 Corbion Recent Developments
- 4.3 DSM
- 4.3.1 DSM Company Information
- 4.3.2 DSM Business Overview
- 4.3.3 DSM Bioresorbable Medical Material Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 DSM Bioresorbable Medical Material Product Portfolio
- 4.3.5 DSM Recent Developments
- 4.4 Mitsui Chemicals
- 4.4.1 Mitsui Chemicals Company Information
- 4.4.2 Mitsui Chemicals Business Overview
- 4.4.3 Mitsui Chemicals Bioresorbable Medical Material Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Mitsui Chemicals Bioresorbable Medical Material Product Portfolio
- 4.4.5 Mitsui Chemicals Recent Developments
- 4.5 PCAS
- 4.5.1 PCAS Company Information
- 4.5.2 PCAS Business Overview
- 4.5.3 PCAS Bioresorbable Medical Material Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 PCAS Bioresorbable Medical Material Product Portfolio
- 4.5.5 PCAS Recent Developments
- 4.6 Poly-Med
- 4.6.1 Poly-Med Company Information
- 4.6.2 Poly-Med Business Overview
- 4.6.3 Poly-Med Bioresorbable Medical Material Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Poly-Med Bioresorbable Medical Material Product Portfolio
- 4.6.5 Poly-Med Recent Developments
- 4.7 KLS Martin
- 4.7.1 KLS Martin Company Information
- 4.7.2 KLS Martin Business Overview
- 4.7.3 KLS Martin Bioresorbable Medical Material Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 KLS Martin Bioresorbable Medical Material Product Portfolio
- 4.7.5 KLS Martin Recent Developments
5 Global Bioresorbable Medical Material Market Scenario by Region
- 5.1 Global Bioresorbable Medical Material Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Bioresorbable Medical Material Sales by Region: 2021-2032
- 5.2.1 Global Bioresorbable Medical Material Sales by Region: 2021-2026
- 5.2.2 Global Bioresorbable Medical Material Sales by Region: 2027-2032
- 5.3 Global Bioresorbable Medical Material Revenue by Region: 2021-2032
- 5.3.1 Global Bioresorbable Medical Material Revenue by Region: 2021-2026
- 5.3.2 Global Bioresorbable Medical Material Revenue by Region: 2027-2032
- 5.4 North America Bioresorbable Medical Material Market Facts & Figures by Country
- 5.4.1 North America Bioresorbable Medical Material Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Bioresorbable Medical Material Sales by Country (2021-2032)
- 5.4.3 North America Bioresorbable Medical Material Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Bioresorbable Medical Material Market Facts & Figures by Country
- 5.5.1 Europe Bioresorbable Medical Material Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Bioresorbable Medical Material Sales by Country (2021-2032)
- 5.5.3 Europe Bioresorbable Medical Material Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Bioresorbable Medical Material Market Facts & Figures by Country
- 5.6.1 Asia Pacific Bioresorbable Medical Material Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Bioresorbable Medical Material Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Bioresorbable Medical Material Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Bioresorbable Medical Material Market Facts & Figures by Country
- 5.7.1 South America Bioresorbable Medical Material Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Bioresorbable Medical Material Sales by Country (2021-2032)
- 5.7.3 South America Bioresorbable Medical Material Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Bioresorbable Medical Material Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Bioresorbable Medical Material Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Bioresorbable Medical Material Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Bioresorbable Medical Material Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Bioresorbable Medical Material Sales by Type (2021-2032)
- 6.1.1 Global Bioresorbable Medical Material Sales by Type (2021-2032) & (K MT)
- 6.1.2 Global Bioresorbable Medical Material Sales Market Share by Type (2021-2032)
- 6.2 Global Bioresorbable Medical Material Revenue by Type (2021-2032)
- 6.2.1 Global Bioresorbable Medical Material Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Bioresorbable Medical Material Revenue Market Share by Type (2021-2032)
- 6.3 Global Bioresorbable Medical Material Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Bioresorbable Medical Material Sales by Application (2021-2032)
- 7.1.1 Global Bioresorbable Medical Material Sales by Application (2021-2032) & (K MT)
- 7.1.2 Global Bioresorbable Medical Material Sales Market Share by Application (2021-2032)
- 7.2 Global Bioresorbable Medical Material Revenue by Application (2021-2032)
- 7.2.1 Global Bioresorbable Medical Material Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Bioresorbable Medical Material Revenue Market Share by Application (2021-2032)
- 7.3 Global Bioresorbable Medical Material Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Bioresorbable Medical Material Value Chain Analysis
- 8.1.1 Bioresorbable Medical Material Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Bioresorbable Medical Material Production Mode & Process
- 8.2 Bioresorbable Medical Material Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Bioresorbable Medical Material Distributors
- 8.2.3 Bioresorbable Medical Material Customers
9 Global Bioresorbable Medical Material Analyzing Market Dynamics
- 9.1 Bioresorbable Medical Material Industry Trends
- 9.2 Bioresorbable Medical Material Industry Drivers
- 9.3 Bioresorbable Medical Material Industry Opportunities and Challenges
- 9.4 Bioresorbable Medical Material Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst